Literature DB >> 28109016

Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version.

Alessandra Iurlo1, Umberto Gianelli2, Daniele Cattaneo1, Juergen Thiele3, Attilio Orazi4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28109016     DOI： 10.1002/ajh.24657

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Impact of World Health Organization (WHO) Revised Criteria-2016 on the Diagnosis of Polycythemia Vera.

Authors:  Shrinidhi Nathany; Sindhura Lakshmi Koulmane Laxminarayana; Siddharth Tewari; Sushma Belurkar; Ruchee Khanna; Chethan Manohar
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-09       Impact factor: 0.900

Review 2.  The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.

Authors:  Tiziano Barbui; Jürgen Thiele; Heinz Gisslinger; Hans Michael Kvasnicka; Alessandro M Vannucchi; Paola Guglielmelli; Attilio Orazi; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2018-02-09       Impact factor: 11.037

Review 3.  New Perspectives on Polycythemia Vera: From Diagnosis to Therapy.

Authors:  Alessandra Iurlo; Daniele Cattaneo; Cristina Bucelli; Luca Baldini
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

4.  Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study.

Authors:  Daniele Cattaneo; Giorgio Alberto Croci; Cristina Bucelli; Silvia Tabano; Marta Giulia Cannone; Gabriella Gaudioso; Maria Chiara Barbanti; Kordelia Barbullushi; Paola Bianchi; Elisa Fermo; Sonia Fabris; Luca Baldini; Umberto Gianelli; Alessandra Iurlo
Journal:  Front Oncol       Date:  2021-03-12       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.